SlideShare a Scribd company logo
Contract and Consumer law
   Thalidomide first appeared in Germany in October
    1957

   The drug was introduced to the UK
    in 1958 under its brand name
    Distaval.

   The drug was mainly given to pregnant women for
    morning sickness.

   On 27 November 1961 Thalidomide was withdrawn in
    the UK from the British manufacture Distillers
    Biochemical LTD.
   The first British thalidomide victim was born
    in January 1959.

   There are currently 455 thalidomide survivors
    in the UK.

   In 1976 it was revealed that Distillers had not
    met the basic testing requirements of the
    time.
   The victim's disabilities range from
    missing limbs and internal
    deformities.

   it is estimated around 40% of thalidomide
    victims died before their first birthday.

   The Thalidomide Trust was established in
    August 1973, to provide support
   Sue for tort of negligence – civil law

   High court – Queen’s Bench

   First case Donoghue v Stevenson 1932

   Must prove duty of care and breach of duty i.e.
    fault

   The Congenital Disabilities (Civil Liability) Act
    1976 – duty of care owed to unborn child
   Breach of duty hard to prove – what would other
    manufacturers have done? Had they taken all
    reasonable care?

   Daniels v White & Son – 14 year old girl sniffing
    bottles of lemonade – breach of duty not proved

   Difficult /impossible to prove breach – Distillers
    would claim they tested product as any other
    manufacturer would have done – drug was
    licensed

   Any compensation – out of court settlement
   Now strict tortious liability under Consumer
    Protection Act 1984 part 1

   No need to prove fault

   But state of art defence would allow manufacturer to
    escape liability

   State of scientific and technical knowledge –
    manufacturer would only have to carry out tests
    known at the time and those that other
    manufacturers would carry out

   Claim would still fail
   The parents of British Thalidomiders were forced to
    fight a protracted court battle for compensation.

   In 1968 a deal was negotiated with Distillers which
    gave 62 victims compensation in an out of court
    settlement (40% of what they might have won if court
    case had been successful)

   After 1968 many out of court settlements followed

   "Y-list“ - 98 children who were suspected of suffering
    deformities due to the drug, but who could not prove
    it and so were unable to claim compensation.
   In 1972, The Sunday Times published the first in a series of
    articles under the headline “Our Thalidomide Children: a Cause
    for National Shame”

   An injunction was issued to stop the campaign

   The Sunday Times then decided to fight the injunction on its
    investigation into the origins and testing of the drug.

 The case went right through the British legal system and up to
  the European Court of Human Rights, which decided that the
  injunction violated the right of “freedom of expression”.
http://www.hrcr.org/safrica/limitations/sunday_times_uk.html
   1973 after 11 year campaign Distillers agreed to pay
    £20 million and to set up a trust fund for victims

   In 2005 Distillers, now part of Diageo, agreed an
    extra one-off payment worth 70% of the annual
    payments

   In 2010 Government issues long-awaited apology
    and a new £20m compensation package to 466
    thalidomiders

   Currently in the UK victims receive, on average
    £18,000 a year

More Related Content

What's hot

Safety monitoring in clinical trails
Safety monitoring in clinical trailsSafety monitoring in clinical trails
Safety monitoring in clinical trails
GOURIPRIYA L S
 
Regulatory Control of Clinical Trials
Regulatory Control of Clinical TrialsRegulatory Control of Clinical Trials
Regulatory Control of Clinical Trials
European Industrial Pharmacists Group
 
Drug development process.
Drug development process.Drug development process.
Drug development process.
Akhil Joseph
 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
National Alopecia Areata Foundation
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
MOHAMMEDSALEEMJM
 
Pharmacovigilance full information
Pharmacovigilance full informationPharmacovigilance full information
Pharmacovigilance full informationRavindra Kumar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Asma Ashraf
 
ICH E2A GUIDELINE
ICH E2A GUIDELINEICH E2A GUIDELINE
ICH E2A GUIDELINE
sathishat9
 
Ndct rule 2019 (manisha)
Ndct rule 2019 (manisha)Ndct rule 2019 (manisha)
Ndct rule 2019 (manisha)
ManishaChauhan86
 
clinical trials types and design
clinical trials types and designclinical trials types and design
clinical trials types and design
Uttara Joshi
 
Case Report Form (CRF)
Case Report Form (CRF)Case Report Form (CRF)
Case Report Form (CRF)
Neelam Shinde
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Satya Prakash Dixit
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
Prasad Bhat
 
Sulfanilamide Tragedy
Sulfanilamide Tragedy Sulfanilamide Tragedy
Sulfanilamide Tragedy
ClinosolIndia
 
Abbreviated new drug application submission
Abbreviated new drug application submissionAbbreviated new drug application submission
Abbreviated new drug application submission
Gaurav Sharma
 
METHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEMETHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCE
Dr Arathy R Nath
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
Prof. Dr. Basavaraj Nanjwade
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
Dr. Pankaj Bablani
 

What's hot (20)

Safety monitoring in clinical trails
Safety monitoring in clinical trailsSafety monitoring in clinical trails
Safety monitoring in clinical trails
 
Regulatory Control of Clinical Trials
Regulatory Control of Clinical TrialsRegulatory Control of Clinical Trials
Regulatory Control of Clinical Trials
 
Drug development process.
Drug development process.Drug development process.
Drug development process.
 
Schedule y
Schedule ySchedule y
Schedule y
 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
 
Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator Roles and Responsibilities of sponsor, CRO, and investigator
Roles and Responsibilities of sponsor, CRO, and investigator
 
Pharmacovigilance full information
Pharmacovigilance full informationPharmacovigilance full information
Pharmacovigilance full information
 
Schedule y
Schedule ySchedule y
Schedule y
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
ICH E2A GUIDELINE
ICH E2A GUIDELINEICH E2A GUIDELINE
ICH E2A GUIDELINE
 
Ndct rule 2019 (manisha)
Ndct rule 2019 (manisha)Ndct rule 2019 (manisha)
Ndct rule 2019 (manisha)
 
clinical trials types and design
clinical trials types and designclinical trials types and design
clinical trials types and design
 
Case Report Form (CRF)
Case Report Form (CRF)Case Report Form (CRF)
Case Report Form (CRF)
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
 
Sulfanilamide Tragedy
Sulfanilamide Tragedy Sulfanilamide Tragedy
Sulfanilamide Tragedy
 
Abbreviated new drug application submission
Abbreviated new drug application submissionAbbreviated new drug application submission
Abbreviated new drug application submission
 
METHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEMETHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCE
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
 

Viewers also liked

Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Govt Medical College & Hospital, Sector-32
 
thalidomide
thalidomidethalidomide
thalidomide
Yokhebed Fransisca
 
The thalidomide saga
The  thalidomide sagaThe  thalidomide saga
The thalidomide saga
Katie Strong
 
Chiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry PerspectiveChiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry PerspectiveBhaswat Chakraborty
 
Who art & med dra
Who art & med draWho art & med dra
Who art & med dra
Plessan Joy
 
Propuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix vallesPropuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix vallesyanielisrodriguez
 
Devitalisation of Thalidomide
Devitalisation of ThalidomideDevitalisation of Thalidomide
Devitalisation of Thalidomide
Dr Yugandar
 
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....Chitta Chowdhury
 
Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2
Carmel Daly
 
Pharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMSPharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMS
Dr.Sharad H. Gajuryal
 
يصثيصيص ي
يصثيصيص ييصثيصيص ي
يصثيصيص ي
researchcenterm
 
Assignment on isomerism
Assignment on isomerismAssignment on isomerism
Assignment on isomerism
azamushahiullah prottoy
 
Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014
researchcenterm
 
Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123
shraddha khairnar
 
How to present a poster (1)
How to present a poster (1)How to present a poster (1)
How to present a poster (1)
researchcenterm
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
Safaa Ali
 
Role of Enantiomers in Pharmacology
Role of Enantiomers in PharmacologyRole of Enantiomers in Pharmacology
Role of Enantiomers in Pharmacology
Dr. Prashant Shukla
 
Receptor down regulation
Receptor down regulationReceptor down regulation
Receptor down regulation
Chander K Negi
 
Receptor regulation and diseases
Receptor regulation and diseasesReceptor regulation and diseases
Receptor regulation and diseases
PLESSAN
 

Viewers also liked (20)

Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
 
thalidomide
thalidomidethalidomide
thalidomide
 
The thalidomide saga
The  thalidomide sagaThe  thalidomide saga
The thalidomide saga
 
Chiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry PerspectiveChiral Separation A pharma Industry Perspective
Chiral Separation A pharma Industry Perspective
 
Who art & med dra
Who art & med draWho art & med dra
Who art & med dra
 
Propuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix vallesPropuesta rise thalidomide.ppt felix valles
Propuesta rise thalidomide.ppt felix valles
 
Devitalisation of Thalidomide
Devitalisation of ThalidomideDevitalisation of Thalidomide
Devitalisation of Thalidomide
 
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
Spatial distributiion mapping of drinking water fluoride levels in Karnataka....
 
Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2Thalidomide The Irish Experience Presentation2
Thalidomide The Irish Experience Presentation2
 
Pharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMSPharmacovigilance at Trauma Center, AIIMS
Pharmacovigilance at Trauma Center, AIIMS
 
Geriatr007
Geriatr007Geriatr007
Geriatr007
 
يصثيصيص ي
يصثيصيص ييصثيصيص ي
يصثيصيص ي
 
Assignment on isomerism
Assignment on isomerismAssignment on isomerism
Assignment on isomerism
 
Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014Ethics of scientific research rc d ec 2014
Ethics of scientific research rc d ec 2014
 
Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123Shraddha pre on 3 r new presen 123
Shraddha pre on 3 r new presen 123
 
How to present a poster (1)
How to present a poster (1)How to present a poster (1)
How to present a poster (1)
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
 
Role of Enantiomers in Pharmacology
Role of Enantiomers in PharmacologyRole of Enantiomers in Pharmacology
Role of Enantiomers in Pharmacology
 
Receptor down regulation
Receptor down regulationReceptor down regulation
Receptor down regulation
 
Receptor regulation and diseases
Receptor regulation and diseasesReceptor regulation and diseases
Receptor regulation and diseases
 

Similar to Thalidomide

Reputation Management
Reputation ManagementReputation Management
Reputation Managementm_gill
 
Tobacco Tort Litigation
Tobacco Tort LitigationTobacco Tort Litigation
Tobacco Tort Litigation
tsesa
 
Global Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual PropertyGlobal Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual Property
Michael Swit
 
NEGLIGENCE17[2].ppt
NEGLIGENCE17[2].pptNEGLIGENCE17[2].ppt
NEGLIGENCE17[2].ppt
VaishnaviElumalai
 
Legal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media SectorLegal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media Sectoremilyaldredd
 
History & Evolution of GMP Regulations
History & Evolution of GMP RegulationsHistory & Evolution of GMP Regulations
History & Evolution of GMP Regulations
GMP EDUCATION : Not for Profit Organization
 
Tobacco conspiracy
Tobacco conspiracyTobacco conspiracy
Tobacco conspiracy
Tarunabh Verma
 
SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15
Michelle Meyer
 
Cameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration ExperienceCameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration ExperienceCameron Diver
 
Introduction to the regulatory affairs
Introduction to the regulatory affairsIntroduction to the regulatory affairs
Introduction to the regulatory affairs
Chandra Mohan
 
8.advert.2020.online
8.advert.2020.online8.advert.2020.online
8.advert.2020.online
Bill Kovarik
 
Concerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docxConcerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docx
ladonnacamplin
 
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
Bashar H. Malkawi
 
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James LoveGSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
MakeMedicinesAffordable
 
Federal hazardous substances act
Federal hazardous substances actFederal hazardous substances act
Federal hazardous substances actSaurabh Mishra
 
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docxMultiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
adelaidefarmer322
 
Liability round up - january 2010
Liability round up - january 2010Liability round up - january 2010
Liability round up - january 2010
QBE European Operations
 
Soc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The LawSoc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The Law
Michelle Cottrell
 

Similar to Thalidomide (20)

Breast Implants
Breast ImplantsBreast Implants
Breast Implants
 
Reputation Management
Reputation ManagementReputation Management
Reputation Management
 
1 gmp essentials
1 gmp essentials1 gmp essentials
1 gmp essentials
 
Tobacco Tort Litigation
Tobacco Tort LitigationTobacco Tort Litigation
Tobacco Tort Litigation
 
Global Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual PropertyGlobal Harmonization Issues and the Protection of Intellectual Property
Global Harmonization Issues and the Protection of Intellectual Property
 
NEGLIGENCE17[2].ppt
NEGLIGENCE17[2].pptNEGLIGENCE17[2].ppt
NEGLIGENCE17[2].ppt
 
Legal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media SectorLegal and Ethical Constraints in the Creative Media Sector
Legal and Ethical Constraints in the Creative Media Sector
 
History & Evolution of GMP Regulations
History & Evolution of GMP RegulationsHistory & Evolution of GMP Regulations
History & Evolution of GMP Regulations
 
Tobacco conspiracy
Tobacco conspiracyTobacco conspiracy
Tobacco conspiracy
 
SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15SOC 204 Goldberg ch 4 f2f Fall15
SOC 204 Goldberg ch 4 f2f Fall15
 
Cameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration ExperienceCameron Diver Summary of International Arbitration Experience
Cameron Diver Summary of International Arbitration Experience
 
Introduction to the regulatory affairs
Introduction to the regulatory affairsIntroduction to the regulatory affairs
Introduction to the regulatory affairs
 
8.advert.2020.online
8.advert.2020.online8.advert.2020.online
8.advert.2020.online
 
Concerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docxConcerns over national security and the environment led congress to .docx
Concerns over national security and the environment led congress to .docx
 
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
 
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James LoveGSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
GSIPA2M, Parallel session 2, Making compulsory licenses routine - James Love
 
Federal hazardous substances act
Federal hazardous substances actFederal hazardous substances act
Federal hazardous substances act
 
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docxMultiple-Choice 2 points each.Pick the best answer; put answers .docx
Multiple-Choice 2 points each.Pick the best answer; put answers .docx
 
Liability round up - january 2010
Liability round up - january 2010Liability round up - january 2010
Liability round up - january 2010
 
Soc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The LawSoc 204 Goldberg Chapter 4 Drugs & The Law
Soc 204 Goldberg Chapter 4 Drugs & The Law
 

Thalidomide

  • 2. Thalidomide first appeared in Germany in October 1957  The drug was introduced to the UK in 1958 under its brand name Distaval.  The drug was mainly given to pregnant women for morning sickness.  On 27 November 1961 Thalidomide was withdrawn in the UK from the British manufacture Distillers Biochemical LTD.
  • 3. The first British thalidomide victim was born in January 1959.  There are currently 455 thalidomide survivors in the UK.  In 1976 it was revealed that Distillers had not met the basic testing requirements of the time.
  • 4. The victim's disabilities range from missing limbs and internal deformities.  it is estimated around 40% of thalidomide victims died before their first birthday.  The Thalidomide Trust was established in August 1973, to provide support
  • 5. Sue for tort of negligence – civil law  High court – Queen’s Bench  First case Donoghue v Stevenson 1932  Must prove duty of care and breach of duty i.e. fault  The Congenital Disabilities (Civil Liability) Act 1976 – duty of care owed to unborn child
  • 6. Breach of duty hard to prove – what would other manufacturers have done? Had they taken all reasonable care?  Daniels v White & Son – 14 year old girl sniffing bottles of lemonade – breach of duty not proved  Difficult /impossible to prove breach – Distillers would claim they tested product as any other manufacturer would have done – drug was licensed  Any compensation – out of court settlement
  • 7. Now strict tortious liability under Consumer Protection Act 1984 part 1  No need to prove fault  But state of art defence would allow manufacturer to escape liability  State of scientific and technical knowledge – manufacturer would only have to carry out tests known at the time and those that other manufacturers would carry out  Claim would still fail
  • 8. The parents of British Thalidomiders were forced to fight a protracted court battle for compensation.  In 1968 a deal was negotiated with Distillers which gave 62 victims compensation in an out of court settlement (40% of what they might have won if court case had been successful)  After 1968 many out of court settlements followed  "Y-list“ - 98 children who were suspected of suffering deformities due to the drug, but who could not prove it and so were unable to claim compensation.
  • 9. In 1972, The Sunday Times published the first in a series of articles under the headline “Our Thalidomide Children: a Cause for National Shame”  An injunction was issued to stop the campaign  The Sunday Times then decided to fight the injunction on its investigation into the origins and testing of the drug.  The case went right through the British legal system and up to the European Court of Human Rights, which decided that the injunction violated the right of “freedom of expression”. http://www.hrcr.org/safrica/limitations/sunday_times_uk.html
  • 10. 1973 after 11 year campaign Distillers agreed to pay £20 million and to set up a trust fund for victims  In 2005 Distillers, now part of Diageo, agreed an extra one-off payment worth 70% of the annual payments  In 2010 Government issues long-awaited apology and a new £20m compensation package to 466 thalidomiders  Currently in the UK victims receive, on average £18,000 a year